Non invasive in vivo imaging of pathological fibrin deposition in the human brain
人脑病理性纤维蛋白沉积的无创体内成像
基本信息
- 批准号:10569064
- 负责人:
- 金额:$ 25.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AffinityAgeAlzheimer&aposs DiseaseAnatomyAnimalsAreaAutopsyBindingBlood - brain barrier anatomyBlood VesselsBrainCentral Nervous System DiseasesClinical assessmentsCoagulation ProcessCountryDataDemyelinationsDepositionDetectionDiagnosticDiseaseDisease MarkerEndotheliumEpitopesEventExcretory functionFibrinFibrinogenGadoliniumGeneral HospitalsGlycoproteinsHemostatic functionHumanImageIndividualInflammationInjectionsKidneyLesionLinkLocalized LesionMagnetic ResonanceMagnetic Resonance ImagingMassachusettsMeasuresMeningealMetabolicMolecularMolecular WeightMonitorMultiple SclerosisNerve DegenerationNeurodegenerative DisordersNeurologicPathogenesisPathologicPathologic ProcessesPathologyPathway interactionsPatientsPenetrationPersonsPlasma ProteinsPositron-Emission TomographyRadiology SpecialtyReportingSafetySamplingScanningSecondary Progressive Multiple SclerosisSerum ProteinsSiteSurrogate MarkersSystemThinnessThrombinTight JunctionsTimeTissuesTracerTranslatingTraumaTraumatic Brain InjuryVisualizationblood-brain barrier disruptiondisabilityhistopathological examinationimaging approachimaging probein vivoin vivo imagingmolecular imagingmultiple sclerosis patientnanomolarnervous system disorderneuroinflammationneuron lossneuropathologynovelnovel markerradiotracersextissue repairtoolultra high resolutionuptakewhite matteryoung adult
项目摘要
Abstract:
A growing body of evidence indicates that fibrinogen and the pathways that control the
formation and degradation of fibrin could represent early triggers that contribute to the
initiation of neuroinflammation and the promotion of neurodegeneration in a variety of
neurological disorders including traumatic brain injury, Alzheimer disease, and multiple
sclerosis (MS), a neuroinflammatory and neurodegenerative disorder of the CNS and the
second most common cause of neurological disability (after trauma) in young adults in
Western countries. Fibrinogen is a 340 kDa glycoprotein generally considered a good
surrogate marker of blood brain barrier (BBB) disruption because of its abundance,
restriction to the intravascular compartment and lack of expression in the healthy CNS.
Upon activation of the coagulation cascade, fibrinogen is converted into insoluble fibrin
by thrombin. Previous studies have demonstrated that fibrin deposition is a prominent
pathological feature of MS and is present throughout the course of the disease.
Neuropathological examinations of ex vivo progressive MS brains have provided
evidence that fibrin deposition in the disease is not only confined to the white matter
(WM), but it can be also extensive and frequent in the MS cortex, where it correlates with
neuronal loss. In MS, cortical demyelination and neurodegeneration represent main
components of disease pathology, particularly in progressive stages, and key substrates
of irreversible neurological disability.
Here, we propose to combine 7-Tesla ultra-high resolution magnetic resonance
imaging (MRI), which shows increased sensitivity relative to lower field MRI to cortical
lesion pathology, with molecular positron emission tomography using 64Cu-FBP8, a
novel molecular imaging probe developed at Massachusetts General Hospital, which
selectively binds to fibrin, to image and quantify in vivo pathological deposition of fibrin in
the brain of people with progressive MS, with a specific focus on the cortex and its
association to local lesions and tissue loss. Safety data demonstrate that 64Cu-FBP8
shows nanomolar affinity for fibrin, high selectivity for fibrin over plasma proteins, is
metabolically stable, and is rapidly renally excreted.The ability to track in vivo fibrin
deposition in MS will be crucial for better understanding the pathological events that lead
to neuroinflammation and cortical damage in MS, and for developing novel biomarkers
for monitoring early events that lead to neuroinflammation in MS.
摘要:
越来越多的证据表明,纤维蛋白原和控制
纤维蛋白的形成和降解可能是导致
在多种疾病中引发神经炎症和促进神经变性
神经疾病,包括创伤性脑损伤、阿尔茨海默病和多发性
硬化症(MS),一种中枢神经系统的神经炎性和神经退行性疾病
年年轻人神经功能障碍(仅次于创伤)的第二大常见原因
西方国家。纤维蛋白原是一种340 kDa的糖蛋白,通常被认为是一种
血脑屏障(BBB)破坏的替代标志,因为它的丰富,
仅限于血管内间隔,在健康中枢神经系统中缺乏表达。
一旦凝血级联被激活,纤维蛋白原就会转化为不溶性纤维蛋白。
通过凝血酶。以前的研究表明,纤维蛋白沉积是一种显著的
多发性硬化症的病理特征,并存在于整个病程。
对体外进展性多发性硬化症大脑的神经病理学检查提供了
有证据表明,这种疾病中的纤维蛋白沉积不仅限于脑白质
(Wm),但它在MS皮质也可以广泛和频繁,在那里它与
神经元丢失。在MS中,主要表现为皮质脱髓鞘和神经变性。
疾病病理学的组成部分,特别是进展期,以及关键底物
不可逆转的神经性残疾。
在这里,我们建议结合7-特斯拉超高分辨率磁共振
成像(MRI),显示相对于低场MRI对皮质的敏感度增加
病变病理,用64Cu-FBP8分子正电子发射断层扫描
马萨诸塞州总医院研发的新型分子成像探针
选择性地与纤维蛋白结合,成像和定量纤维蛋白在体内的病理沉积
进行性多发性硬化症患者的大脑,特别关注皮质及其
与局部损伤和组织丢失有关。安全数据表明,64Cu-FBP8
显示对纤维蛋白的纳摩尔亲和力,对纤维蛋白的高选择性超过血浆蛋白,是
代谢稳定,肾脏排泄迅速。体内追踪纤维蛋白的能力
多发性硬化症中的沉积对于更好地理解导致
多发性硬化症的神经炎症和皮质损伤,以及开发新的生物标记物
用于监测导致多发性硬化症神经炎症的早期事件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caterina Mainero其他文献
Caterina Mainero的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caterina Mainero', 18)}}的其他基金
Non invasive in vivo imaging of pathological fibrin deposition in the human brain
人脑病理性纤维蛋白沉积的无创体内成像
- 批准号:
10428755 - 财政年份:2022
- 资助金额:
$ 25.2万 - 项目类别:
In Vivo Imaging of Cortical Glial Activation Using Advanced Diffusion Magnetic Resonance Imaging
使用先进的扩散磁共振成像对皮质胶质激活进行体内成像
- 批准号:
10288188 - 财政年份:2021
- 资助金额:
$ 25.2万 - 项目类别:
Cortical mechanisms of disease progression in early multiple sclerosis
早期多发性硬化症疾病进展的皮质机制
- 批准号:
8730719 - 财政年份:2013
- 资助金额:
$ 25.2万 - 项目类别:
Cortical mechanisms of disease progression in early multiple sclerosis
早期多发性硬化症疾病进展的皮质机制
- 批准号:
8579002 - 财政年份:2013
- 资助金额:
$ 25.2万 - 项目类别:
In vivo Imaging of Brain Damage in HTLV-I Associated Tropical Spastic Paraparesis
HTLV-I 相关热带痉挛性截瘫脑损伤的体内成像
- 批准号:
7425675 - 财政年份:2008
- 资助金额:
$ 25.2万 - 项目类别:
In vivo Imaging of Brain Damage in HTLV-I Associated Tropical Spastic Paraparesis
HTLV-I 相关热带痉挛性截瘫脑损伤的体内成像
- 批准号:
7644895 - 财政年份:2008
- 资助金额:
$ 25.2万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant